Offshore Public Offerings

Companies:

• Jiangxi Institute of Biological Products Inc. in its approximately US$52 million IPO and listing on the Hong Kong Stock Exchange
• TenNor Therapeutics (Suzhou) Limited (6872.HK) in its approximately US$80 million IPO and listing on the Hong Kong Stock Exchange
• Distinct Healthcare Holdings Limited (2677.HK) in its approximately US$36 million IPO and listing on the Hong Kong Stock Exchange
• Vigonvita Life Sciences Co., Ltd. (2630.HK) in its approximately HK$600 million (approximately US$77 million) IPO and listing on the Hong Kong Stock Exchange
• TransThera Sciences (2617.HK) in approximately US$25 million listing of H shares on the Hong Kong Exchange
• TYK Medicines in its approximately US$74 million IPO and listing on the Hong Kong Stock Exchange
• Horizon Construction Development Limited in its approximately HK$1.65 billion IPO and listing on the Hong Kong Stock Exchange
• Ferretti S.p.A. in its approximately HK$1.9 billion IPO and listing on the Hong Kong Stock Exchange
• Simcere Pharmaceutical Group Limited in its US$461 million IPO and listing on the Hong Kong Stock Exchange
• Hygeia Healthcare Holdings Co., Limited in its US$286 million IPO and listing on the Hong Kong Stock Exchange
• Netjoy Holdings Limited in its US$180 million IPO and listing on the Hong Kong Stock Exchange
• Strawbear Entertainment Group in its US$137 million IPO and listing on the Hong Kong Stock Exchange
• Tianjin Tianbao Energy Co., Ltd. in connection with its US$10.66 million IPO and listing on the Hong Kong Stock Exchange
• Jacobson Pharma Corporation Limited in its US$90 million IPO and listing on the Hong Kong Stock Exchange
• Harmonicare Medical Holdings Limited in its US$205 million IPO and listing on the Hong Kong Stock Exchange
• Guorui Properties Limited in its IPO and listing on the Hong Kong Stock Exchange

Underwriters:

• CICC Hong Kong Securities and Citigroup Global Markets as joint sponsors and other underwriters in the approximately US$235 million IPO of Suzhou Ribo Life Science Co., Ltd. (6938.HK) on the Hong Kong Stock Exchange, the second largest Chapter 18A Hong Kong IPO since 2022
• CMB International as sole sponsor and Futu Securities International as joint lead manager in approximately US$115 million IPO of Bayzed Health Group Inc (2609.HK) on the Hong Kong Exchange
• CICC as sponsor in the HK$412 million IPO of BaTeLab Co., Ltd. on the Hong Kong Stock Exchange
• CICC, Haitong International, Huatai International, CLSA and ABC International as underwriters in the US$685 million offering and listing of global depositary receipts of Gotion High-tech Co., Ltd. on the SIX Swiss Exchange
• CLSA, AMTD, CICC and CMB Securities as underwriters in Bank of Qingdao’s US$64.5 million H-share rights issuance
• Haitong International and Huatai Financial Holdings (Hong Kong) as sponsors in the US$175 million IPO of Chaoju Eye Care Holdings on the Hong Kong Stock Exchange
• Morgan Stanley and CLSA as sponsors in the US$160 million IPO of CanSino Biologics on the Hong Kong Stock Exchange
• Deutsche Securities Asia and Haitong International as sponsors in the US$96 million IPO of Weimob on the Hong Kong Stock Exchange
• BOCI Asia and Citigroup Global Markets Asia as sponsors in the US$208 million IPO of VPower Group International Holdings on the Hong Kong Stock Exchange
• BAML and Morgan Stanley as sponsors in the US$1.15 billion IPO of Dali Foods Group Company Limited on the Hong Kong Exchange
• ICBC International as sponsor in the US$38.6 million IPO of Chen Xing Development Holdings Limited on the Hong Kong Exchange

Debt Capital Markets and Others

• Yue Xiu Enterprises Holdings Limited in the issuance of US$200 million principal amount of 1.50% guaranteed exchangeable bonds by its wholly-owned subsidiary
• CSR Corporation Limited in its US$26 billion merger with China CNR Corporation Limited
• CRCC Limited in the issuance of US$800 million principal amount of 3.95% senior guaranteed perpetual securities by its wholly-owned subsidiary
• CRCC Limited in the issuance of US$800 million principal amount of 3.50% guaranteed notes by its wholly-owned subsidiary
• The independent committee of the board of directors of 7 Days Group Holdings Limited in its going private transaction
• JinkoSolar Holding Co., Ltd. in its offering of US$125 million principal amount of 4.00% convertible senior notes

* Including work performed prior to joining O’Melveny and ongoing proposed listing matters